Prognostic impact of ABO blood group on type I endometrial cancer in a population of Iranian patients

2020 ◽  
Vol 28 (4) ◽  
pp. 313-317
Author(s):  
Shima Mohammadian ◽  
Farkhondeh Pouresmaeili ◽  
Aida Mohammadian
Keyword(s):  
Blood Group ◽  
Significant Relationship ◽  
Blood Groups ◽  
Abo Blood Group ◽  
Type I ◽  
Prognostic Impact ◽  
Abo Blood Groups ◽  
Blood Group A ◽  
Group A ◽  
Iranian Patients

BACKGROUND: Inherited ABO blood group has been shown to play an important role in the pathogenesis of various gynecological cancers including endometrial carcinoma (EC). OBJECTIVE: Our study aimed to determine the prevalence of ABO blood groups in Iranian patients with EC and to investigate the relationship between the blood group and several clinicopathologic parameters in Imam Hossein Hospital. METHODS: One hundred and seventy-five EC patients were selected and analyzed for their clinicopathologic details including ABO blood group, age, menopausal status, body mass index (BMI), tumor grade, and stage of the International Federation of Obstetrics and Gynecology (FIGO). RESULTS: Endometrioid carcinoma was the most common histological type in this case study. Early stages (I and II) were present in 135 individuals (77.1%) and advanced stages (III and IV) appeared in 40 (22.9%) patients. Blood group A was prominent in patients with EC. There was a significant relationship between blood group A and cancer grade (P= 0.024). 23.1% of group A had grade III EC, while this grade appeared in 35.2% of the non-A blood group. There was no significant association between ABO blood groups and other EC clinic-pathological results (P> 0.05). CONCLUSION: Although there was no significant relationship between the ABO blood group and the patients’ clinicopathological characteristics, more studies could provide extensive information about any possible relation between the blood group, especially blood group A, EC, and the grade of the tumor.

scholarly journals ABO Blood Group is Associated with COVID-19 Susceptibility: a Systematic Review and Meta-Analysis

2020 ◽  
Vol 3 (1) ◽  
pp. 71-84
Author(s):  
Richard Chinaza Ikeagwulonu ◽  
◽  
Chinonyelum Thecla Ezeonu ◽  
Mark Uchejeso Obeta ◽  
Ngozi Immaculata Ugwu ◽  
...  
Keyword(s):  
Blood Group ◽  
Meta Analysis ◽  
Blood Groups ◽  
Blood Type ◽  
Abo Blood Group ◽  
Abo Blood Groups ◽  
Blood Group A ◽  
Search Terms ◽  
Group A

Introduction: Conflicting evidences exist that ABO blood groups correlate with the susceptibility to COVID-19 and its clinical outcomes. This study aimed to pool available articles that assessed a possible relationship between COVID-19 and ABO blood groups. Materials and methods: A search was conducted in four databases comprising Pubmed/Medline, Google scholar, Journal storage (JSTOR) and African Journals Online (AJOL) for relevant studies available before 25th August 2020 and contained extractable data on ABO blood type distribution and COVID-19 disease. Search terms included a combination of “ABO blood group, and COVID-19, coronavirus, and SARS-COV-2”. Results: Fourteen articles that met study inclusion criteria were selected from a total of five hundred and eighty-five articles identified through database search. The fourteen articles reviewed comprised of a total of 73934 subjects (13189 SARS-COV-2 positive cases and 60745 controls). Overall, the risk of SARS-COV-2 infection was found to be significantly increased in patients with blood group A with ORs: 1.24 (95%Cl: 1.09-1.41, P = 0.001). Additionally, blood group O subjects were seen to have decreased odds of contracting COVID-19 infection (OR: 0.78, 95%Cl: 0.68 – 0.89, P=0.0003). No significant association was found between ABO blood groups and COVID -19 severity and mortality. Conclusions: Blood group A was associated with a higher risk of SARS-COV-2 infection whereas risk of infection was lower in blood group O subjects. No statistical significant association was found between ABO blood groups and COVID-19 severity and mortality. The precise role of ABO blood group in COVID-19 susceptibility, severity and mortality requires further research for clarification.

scholarly journals Variations of prothrombin time among ABO blood groups in healthy adults

2021 ◽  
Vol 11 (3) ◽  
pp. 429-435
Author(s):  
Afrina Binte Azad ◽  
Qazi Shamima Akhter ◽  
Mohammad Aminul Islam ◽  
Farzana Yeasmin Mukta ◽  
Lily Afroz ◽  
...  
Keyword(s):  
Prothrombin Time ◽  
Blood Group ◽  
Blood Groups ◽  
Healthy Adults ◽  
Abo Blood Group ◽  
Abo Blood Groups ◽  
Medical College ◽  
Blood Group A ◽  
Group A ◽  
Group B

Background and objectives: ABO blood group distribution defers with racial and geographic variations. They are related with diseases like cardiovascular diseases, cerebral thromboembolism. Prothrombin time may varies among ABO blood group system which may increase the future risk of thrombosis. The present study is to assess prothrombin time among ABO blood groups in healthy adults. Materials and methods: A prospective type of analytical cross-sectional study was conducted in the Department of Physiology, Dhaka Medical College, Dhaka from July 2019 to June 2020. After obtaining ethical clearance, a total 190 healthy adults were selected from different areas of Dhaka city based on inclusion and exclusion criteria, with age ranging from 18-45 years. The subjects were interviewed and detailed history regarding personal, family, medical and drug were taken. Prior to sample collection, informed written consent was taken from the participants. Individuals of blood group A was selected as group A, blood group B as group B, blood group AB as group AB and blood group O as group O. Prothrombin time was measured in the Department of Hematology and BMT Unit, Dhaka Medical College Hospital, Dhaka. Blood grouping was done in the Department of Physiology, Dhaka Medical College, Dhaka.For statistical analysis, One way ANOVA followed by Bonferroni test were considered using SPSS 25.0 version. Results: In this study, blood group B was most common (33.2%). Prothrombin time was lower in blood group A (12.93±0.30 sec), B (12.92±0.61 sec), AB (12.98±0.54 sec) than blood group O (13.08±0.39 sec) which was not statistically significant. Conclusion: It can be concluded that blood group A, B, AB individuals may have more chance of thrombosis due to lower prothrombin time than blood group O individuals.

scholarly journals Relative Susceptibilities of ABO Blood Groups toPlasmodium falciparumMalaria in Ghana

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Richmond Afoakwah ◽  
Edmond Aubyn ◽  
James Prah ◽  
Ekene Kwabena Nwaefuna ◽  
Johnson N. Boampong
Keyword(s):  
Falciparum Malaria ◽  
Blood Group ◽  
Malaria Infection ◽  
Blood Groups ◽  
The Other ◽  
Abo Blood Group ◽  
Abo Blood Groups ◽  
Blood Group A ◽  
Complicated Malaria ◽  
Group A

The clinical outcome of falciparum malaria in endemic areas is influenced by erythrocyte polymorphisms including the ABO blood groups. Studies have reported association of ABO blood group to resistance, susceptibility, and severity ofP. falciparummalaria infection. Individuals with blood group “A” have been found to be highly susceptible to falciparum malaria whereas blood group “O” is said to confer protection against complicated cases. We analyzed samples from 293 young children less than six years old with malaria in the Korle-Bu Teaching Hospital in Accra, Ghana. It was observed that group O was present in about 16.1% of complicated cases weighed against 40.9% of uncomplicated controls. Individuals with complicated malaria were about twice likely to be of blood groups A and B compared to group O (A versus O, OR = 1.90, 95% CI = 1.59–2.26,P<0.0001; B versus O, OR = 1.82. 95% CI = 1.57–2.23,P<0.0001). Blood group O participants with complicated diseases had low parasitaemia compared to the other blood groups (P<0.0001). This may give blood group O individuals a survival advantage over the other groups in complicated malaria as suggested. Participants with complicated falciparum malaria were generally anaemic and younger than those with uncomplicated disease.

scholarly journals Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh

PLoS ONE ◽  
2021 ◽  
Vol 16 (4) ◽  
pp. e0249252
Author(s):  
Reaz Mahmud ◽  
Mohammad Aftab Rassel ◽  
Farhana Binte Monayem ◽  
S. K. Jakaria Been Sayeed ◽  
Md Shahidul Islam ◽  
...  
Keyword(s):  
Blood Group ◽  
Blood Groups ◽  
Abo Blood Groups ◽  
Duration Of Symptoms ◽  
Presenting Symptoms ◽  
Blood Group A ◽  
Group I ◽  
Significant Difference ◽  
Group A ◽  
Group Ii

Background Globally, studies have shown conflicting results regarding the association of blood groups with SARS CoV-2 infection. Objective To observe the association between ABO blood groups and the presentation and outcomes of confirmed COVID-19 cases. Design, setting, and participants This was a prospective cohort study of patients with mild-to-moderately severe COVID-19 infections who presented in the COVID-19 unit of Dhaka Medical College Hospital and were enrolled between 01 June and 25 August, 2020. Patients were followed up for at least 30 days after disease onset. We grouped participants with A-positive and A-negative blood groups into group I and participants with other blood groups into group II. Results The cohort included 438 patients; 52 patients were lost to follow-up, five died, and 381 completed the study. The prevalence of blood group A [144 (32.9%)] was significantly higher among COVID-19 patients than in the general population (p < 0.001). The presenting age [mean (SD)] of group I [42.1 (14.5)] was higher than that of group II [38.8 (12.4), p = 0.014]. Sex (p = 0.23) and co-morbidity (hypertension, p = 0.34; diabetes, p = 0.13) did not differ between the patients in groups I and II. No differences were observed regarding important presenting symptoms, including fever (p = 0.72), cough (p = 0.69), and respiratory distress (p = 0.09). There was no significant difference in the median duration of symptoms in the two group (12 days), and conversion to the next level of severity was observed in 26 (20.6%) and 36 patients (13.8%) in group I and II, respectively. However, persistent positivity of RT-PCR at 14 days of initial positivity was more frequent among the patients in group I [24 (19%)] than among those in group II [29 (11.1%)]. Conclusions The prevalence of blood group A was higher among COVID-19 patients. Although ABO blood groups were not associated with the presentation or recovery period of COVID-19, patients with blood group A had delayed seroconversion.

scholarly journals Cardiovascular disease and ABO blood-groups in Africans. Are blood-group A individuals at higher risk of ischemic disease?: A pilot study

2017 ◽  
Vol 69 (4) ◽  
pp. 229-234 ◽  
Author(s):  
Djibril Marie BA ◽  
Mamadou Saidou Sow ◽  
Aminata Diack ◽  
Khadidiatou Dia ◽  
Mouhamed Cherif Mboup ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Pilot Study ◽  
Blood Group ◽  
Blood Groups ◽  
Abo Blood Groups ◽  
Ischemic Disease ◽  
Blood Group A ◽  
Group A

scholarly journals Frequency of ABO and Rhesus blood groups in Saudi healthy blood donors versus non-Saudi in a retrospective study in Makkah City

2021 ◽  
Vol 1 (1) ◽  
pp. 2-13
Author(s):  
Amal z. Moustafa ◽  
Mohammed S. Aldosari ◽  
Talat A. AL-Bukhari ◽  
Younis A. Allohibi ◽  
Shirin H . Teama ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Blood Group ◽  
Blood Donors ◽  
Blood Groups ◽  
Abo Blood Group ◽  
Sri Lankan ◽  
Blood Storage ◽  
Blood Group A ◽  
Group A ◽  
Makkah City

Purpose: to assess the frequency of ABO and Rh blood groups among Saudi and non-Saudi healthy blood donors and to compare between them. Methods: A retrospective study was conducted; in Makkah City, Saudi Arabia. It included 15,365 participants of 44 nationalities who have attended the blood bank of King Abdul Aziz Hospital. The collected data were age, sex, nationality, ABO, and Rhesus blood groups.  Results: 46.8 % of the participants were O, 28.8 % A, 19.5 % B, and 4.9% AB. The nationalities with a higher frequency of blood group O were Saudi, Mauritanian, Yemeni, Thai, Malian, Sudanese, Jordanian, Indian, Moroccan, Somali, Malaysian, Indonesian, Myanmar, Nigerian, Pakistani, Bangladeshi, Algerian, Djibouti, Burkinabe, Eritrean, Ghanaian, Bahraini, Bosnian, Canadian, Gambian, Iraqi, and Sri Lankan. Those with a higher frequency of blood group A were Turkish, Palestinian, Syrian, Lebanese, Egyptian, Afghan, Chadian, French, Tunisian, Cameroonian, Ethiopian, and British.  Those with a higher frequency of B were Nigerien, American, Nepalese, and two nationalities with higher AB frequency Filipino and Chinese. 91.6 % of all populations were Rh-positive, and 8.4% were Rh-negative. The Saudi participants were like some nationalities and differed from others. Conclusion:  In Makkah city, the higher frequency of ABO blood group in Saudi and non -Saudi people is O followed by A, then B, and AB.  The Rh-positive is predominant, and 8.4% of the participants are negative. The ABO and Rh blood groups' identifications are essential for providing suitable blood storage for individuals in need.

scholarly journals Dermatophytosis: association between ABO blood groups and reactivity to the trichophytin

1999 ◽  
Vol 41 (5) ◽  
pp. 285-289 ◽  
Author(s):  
Fátima Regina VILANI-MORENO ◽  
Maria Sueli Parreira de ARRUDA ◽  
Simone Guadgnucci CLARO ◽  
Elaine Valim Camarinha MARCOS ◽  
Somei URA
Keyword(s):  
Immune Response ◽  
Blood Group ◽  
Cellular Immune Response ◽  
Blood Groups ◽  
Abo Blood Groups ◽  
Blood Group A ◽  
Number Of Patients ◽  
Group A ◽  
Group B ◽  
Cellular Immune

The authors investigated the relationship between dermatophytosis and ABO blood groups through blood typing, identification of isolated dermatophytes and specific cellular immune response of 40 individuals carriers of this mycosis. They verified that the fungus Trichophyton rubrum, isolated from 54.5% of the patients, was more frequent in individuals belonging to blood group A. The cellular immune response, evaluated through the trichophytin antigen, was positive in 25% of the studied patients; the presence of immediate reactions (30 minutes) was verified in 35%. The blood group distribution among patients with dermatophytosis and control groups was, respectively: 47.5% X 36% in group A, 40% X 50% in group O, 12.5% X 11% in group B. Even though the authors have found a higher number of patients belonging to blood group A infected by T. rubrum, these results suggest that there is no statistical evidence that these individuals are more susceptible to dermatophytosis.

Association of ABO Blood Groups with Incidence of renal Lithiasis

1964 ◽  
Vol 13 (2) ◽  
pp. 167-172 ◽  
Author(s):  
Swadesh Anand
Keyword(s):  
Blood Group ◽  
Blood Groups ◽  
Degree Of Freedom ◽  
Abo Blood Groups ◽  
Renal Lithiasis ◽  
Blood Group A ◽  
Group A ◽  
The Difference

SUMMARY187 patients suffering from renal lithiasis have been examined to find out an association with ABO blood groups. It has been found that the incidence of Renal Lithiasis is comparatively higher in the patients of blood group A than in those of blood group O. The difference in percentage ratios A/(A+0)% in patients and controls is 17.96; the χ2 17.4331 for one degree of freedom shows that it differs from unity significantly. The frequencies of renal lithiasis in persons of blood group A against those of B, O and AB are 1.91, 1.59 and 1.31 respectively.

ABO Blood Groups as Risk Factors for Thrombosis

1996 ◽  
Vol 2 (3) ◽  
pp. 196-199 ◽  
Author(s):  
Dayse M. Lourenço ◽  
Fausto Miranda ◽  
Letícia H. C. Lopes
Keyword(s):  
Risk Factors ◽  
Blood Group ◽  
Blood Donors ◽  
Blood Groups ◽  
Abo Blood Groups ◽  
Arterial Embolism ◽  
Fisher Test ◽  
Vein Thrombosis ◽  
Blood Group A ◽  
Group A

To evaluate the relationship between ABO blood group and thrombosis, we studied 127 patients tak ing oral anti-vitamin K drugs for thromboembolism pro phylaxis and compared them with 700 voluntary blood donors. There were 68 patients with venous thrombosis (VT)—68 with deep vein thrombosis and 8 with pulmo nary embolism—and 51 patients with arterial embolism (AE). There were 61 men and 66 women. Mean age at diagnosis was lower for all women, regardless of if they had VT or AE (43 years) than for men (55 years; Kruskal- Wallis test, p < 0.01). There was an imbalance between blood group A and O frequencies in patients with VT versus blood donors, with a higher frequency of blood group A or a lower frequency of blood group O, repre sented by a high A/O ratio. A/O ratio for blood donors was 0.63; it was 1.50 for men (Fisher test, p = 0.028) and 1.44 for women (Fisher test, p = 0.010). Patients with AE showed the same discrepancy, but it was significant for women (A/O = 2.25; Fisher test, p = 0.026) and not for men (A/O = 0.86; Fisher test, p = 0.836), suggesting that men with AE might have other risk factors for thrombo sis. These data are not conclusive about the causes of the association between ABO blood groups and thrombosis, and prospective studies are needed to verify whether blood typing could have a predictive value for prophylatic measures in clinical and surgical patients.

scholarly journals The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility in COVID-19: A Retrospective Population Study of 3305 Patients

Blood ◽  
2020 ◽  
Vol 136 (Supplement 1) ◽  
pp. 32-33
Author(s):  
Waleed Alduaij ◽  
Sarah Al-Youha ◽  
Ahmad Al-Serri ◽  
Sulaiman Almazeedi ◽  
Mohannad Al-Haddad ◽  
...  
Keyword(s):  
General Population ◽  
Clinical Outcomes ◽  
Blood Group ◽  
Blood Groups ◽  
National Database ◽  
Abo Blood Group ◽  
Abo Blood Groups ◽  
Susceptibility To Infection ◽  
Significant Difference ◽  
Group A

Background: Factors determining inherent susceptibility to infection with the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and the risk of severe outcomes in infected individuals remain poorly understood. Landsteiner ABO blood groups have been linked to host susceptibility to various infections through the interaction of the carbohydrate moieties defining ABO antigens with micro-organisms and the immune system. Previous studies of the original SARS coronavirus (SARS-CoV-1) demonstrated a decreased susceptibility to infection in group O individuals (Cheng et al. JAMA 2005; 293:1450-1) and the ability of plasma-derived anti-A antibodies to block the interaction between viral spike protein and human angiotensin-converting enzyme 2 receptor in vitro (Guillon et al. Glycobiology 2008; 18:1085-93). A recent genome-wide association study of patients with respiratory failure complicating coronavirus disease 2019 (COVID-19) suggested a higher risk of severe disease in group A, and a protective effect in group O (Ellinghaus et al. NEJM 2020 DOI:10.1056/NEJMoa2020283). Since the inception of the COVID-19 pandemic, a broad testing strategy was implemented in Kuwait and all individuals testing positive for SARS-CoV-2 were admitted to a single facility, including asymptomatic individuals. Here we examined the clinical outcomes of this cohort with respect to ABO blood group and compared its blood group distribution to that of the general population. Methods: All patients testing positive for SARS-CoV-2 by polymerase chain reaction assay of a nasopharyngeal swab specimen that were admitted to Jaber Hospital between February 24th to May 27th 2020 were included in the study. Relevant demographic and clinical data were extracted from hospital records. An anonymized summary of the distribution of blood types of the entire population of Kuwait was obtained from a national database and used as a control group. Clinical outcomes were in accordance with international consensus definitions. Appropriate statistical tests were used for bivariate analysis. Multivariate logistic regression was performed to determine relationships between variables of interest and outcome. Results: Of 3305 SARS-CoV-2 positive patients 37.1%, 25.5%, 28.9% and 8.5% were group O, A, B and AB respectively. 69.2% were male and 30.8% were female. Median age was 42 years. 48.1% were Kuwaiti citizens and 51.9% were non-Kuwaiti. Commonest comorbidities were hypertension (21.5%) and diabetes (20.1%). 17.4% were obese. 37.2% were asymptomatic on admission. There was no significant difference in baseline characteristics among the blood groups. Univariate analysis of clinical outcomes revealed no significant differences in need for oxygen support, admission to intensive care, intubation or death among the blood groups. However, rates of any adverse event and pneumonia differed significantly (Table 1). Multivariable analysis adjusted for age, sex, obesity and comorbidities showed that group A had higher odds of developing pneumonia compared to the other blood groups combined (adjusted odds ratio 1.32, 95% confidence interval 1.02-1.72, p&lt;0.0363). We found no relationship between pneumonia and other blood groups. Compared to the general population, the COVID-19 cohort had a lower frequency of group O, equivalent frequency of group A and higher frequency of groups B and AB (Table 2). This trend was independent of nationality (Kuwaiti versus non-Kuwaiti). Incorporation of Rh (D) status did not impact the trend observed with ABO blood groups. Finally, no significant difference in Rh (D) status was found between the COVID-19 and general populations (Rh positive 93.4% versus 93.6% respectively, p=0.99) Conclusion: In a large, unselected patient population, no association between blood group and severe clinical outcomes in COVID-19 was found. Consistent with reports in other populations, we found a lower prevalence of blood group O in SARS-CoV-2 positive individuals and higher prevalence of blood group B and AB implicating a potential role of ABO blood group in susceptibility to infection. No association between SARS-CoV-2 infection with blood group A or Rh (D) group was found. Further examination of the mechanistic link between ABO antigens, antibodies and SARS-CoV-2, and its implications on controlling the current pandemic is warranted. Disclosures No relevant conflicts of interest to declare.

Sign in / Sign up

Export Citation Format

Share Document